Heather Booth

Also affiliated with Alexion Pharmaceuticals (United States), Fondazione IRCCS Istituto Neurologico Carlo Besta, Stanford University

MedicineNeuroscienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension”.

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Neurology(2020)10.1212/wnl.0000000000011207

N/A

2.8DataRank · unranked

79 citations

Gil I. Wolfe, Srikanth Muppidi, Heinz Wiendl, Kenji P. Fujita, Fanny O’Brien +94 more

The value of comparing health outcomes in cohort studies: An example of self‐rated health in seven studies including 79 653 participants

Australasian Journal on Ageing(2007)10.1111/j.1741-6612.2007.00261.x

N/A

0.292DataRank · unranked

6 citations

Peter Butterworth, Tim D Windsor, Richard Burns, Kerry Sargent‐Cox, Chwee Von Sanden +13 more